Figure 5
From: Systematic analysis identifies REST as an oncogenic and immunological biomarker in glioma
Relationship between REST and immune checkpoints in glioma. (A) Spearman correlation of REST with expression of PD-1, PD-L1, and CTLA-4 in glioma by TIMER2 (http://timer.cistrome.org/). (B) The expression correlation of REST with PD-1, PD-L1, and CTLA-4 in glioma by GEPIA2 (http://gepia.cancer-pku.cn/).
